Phenotype: increased circulating fructosamine level

Definition increase in the concentration in the blood of total non enzymatic glycated proteins in the blood

Synonyms
  • increased circulating GSP level
  • increased circulating GSP level
  • increased circulating glycated serum protein level
  • increased circulating glycated serum protein level

MP browserMP:0010087

Phenotype associations stats

0.75% of tested genes with null mutations on a B6N genetic background have a phenotype association to increased circulating fructosamine level (15/2011)

0.73% females (14/1928) 0.51% males (10/1950)

Select a parameter    



Gene variants with increased circulating fructosamine level

Total number of significant genotype-phenotype associations: 24

Gene / Allele Zygosity Sex Life Stage Phenotype Procedure | Parameter Phenotyping Center | Source P Value Data
Fam53b
Fam53btm1b(EUCOMM)Hmgu
HOM Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine HMGU | IMPC 3.84E-11
Gck
Gckem1(IMPC)H
HET Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 1.06E-10
Lepr
Leprtm1b(EUCOMM)Wtsi
HOM Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 5.16E-9
Plekhg1
Plekhg1tm1a(EUCOMM)Wtsi
HOM Female postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | MGP 1.29E-7
Akap9
Akap9tm1a(KOMP)Wtsi
HET Female postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | MGP 2.07E-7
Dhdds
Dhddstm1b(KOMP)Wtsi
HET Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine HMGU | IMPC 3.23E-7
Galnt18
Galnt18tm1b(KOMP)Wtsi
HOM Female postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.03E-6
Rab5c
Rab5ctm1a(EUCOMM)Wtsi
HET Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 3.54E-6
Sirt4
Sirt4tm1b(EUCOMM)Hmgu
HOM Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 1.71E-5
Cyb561
Cyb561tm1a(EUCOMM)Wtsi
HOM Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | EuroPhenome 1.72E-5
Serpinb9b
Serpinb9bem1(IMPC)Wtsi
HOM Female postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.98E-5
F730043M19Rik
F730043M19Riktm1b(NCC)WCS
HOM Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 2.18E-5
Arrdc5
Arrdc5tm1b(EUCOMM)Wtsi
HOM Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 6.51E-5
Smim1
Smim1em1(IMPC)Wtsi
HOM Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 7.12E-5
Pex3
Pex3tm1a(EUCOMM)Wtsi
HOM Female postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | EuroPhenome 8.37E-5

Download data as: TSV XLS